Get started
Telix Pharmaceutical Ltd.Telix Pharmaceutical Ltd.Telix Pharmaceutical Ltd.

Telix Pharmaceutical Ltd.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.18 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
209.49
Basic EPS (TTM)
0.03 USD
Net income (FY)
‪30.88 M‬ USD
Revenue (FY)
‪484.55 M‬ USD
Shares float
‪268.29 M‬
Beta (1Y)
1.45

About Telix Pharmaceuticals Limited


Sector
Health Technology
Industry
Biotechnology
CEO
Christian P. Behrenbruch
Website
telixpharma.com
Headquarters
Melbourne
Founded
2017
IPO date
Nov 15, 2017
Identifiers
2
ISIN AU000000TLX2
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Check out other big names from the same industry as TLPPF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VAS
Vanguard Australian Shares Index ETF
Weight
0.12%
Market value
‪37.57 M‬
USD
MVW
VanEck Australian Equal Weight ETF
Weight
0.85%
Market value
‪19.33 M‬
USD
A200
BetaShares Australia 200 ETF
Weight
0.11%
Market value
‪6.88 M‬
USD
SCZ
iShares MSCI EAFE Small-Cap ETF
Weight
0.05%
Market value
‪6.59 M‬
USD
IOZ
iShares Core S&P/ASX 200 ETF
Weight
0.10%
Market value
‪5.65 M‬
USD
STW
State Street SPDR S&P ASX 200 ETF
Weight
0.10%
Market value
‪4.30 M‬
USD
VSO
Vanguard MSCI Australian Small Companies Index ETF
Weight
0.54%
Market value
‪4.27 M‬
USD
FAIR
BetaShares Australian Sustainability Leaders ETF
Weight
0.51%
Market value
‪4.25 M‬
USD
DACE
Dimensional Australian Core Equity Trust Units
Weight
0.08%
Market value
‪3.30 M‬
USD
MVE
VanEck S&P/ASX Midcap ETF
Weight
0.77%
Market value
‪2.64 M‬
USD
VPL
Vanguard FTSE Pacific ETF
Weight
0.02%
Market value
‪2.30 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of TLPPF is 6.61 USD — it has decreased by −4.06% in the past 24 hours. Watch Telix Pharmaceutical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Telix Pharmaceutical Ltd. stocks are traded under the ticker TLPPF.
TLPPF stock has fallen by −8.58% compared to the previous week, the month change is a −11.87% fall, over the last year Telix Pharmaceutical Ltd. has showed a −61.21% decrease.
We've gathered analysts' opinions on Telix Pharmaceutical Ltd. future price: according to them, TLPPF price has a max estimate of 22.77 USD and a min estimate of 11.51 USD. Watch TLPPF chart and read a more detailed Telix Pharmaceutical Ltd. stock forecast: see what analysts think of Telix Pharmaceutical Ltd. and suggest that you do with its stocks.
TLPPF reached its all-time high on Feb 24, 2025 with the price of 24.85 USD, and its all-time low was 0.64 USD and was reached on Mar 12, 2020. View more price dynamics on TLPPF chart.
See other stocks reaching their highest and lowest prices.
TLPPF stock is 7.11% volatile and has beta coefficient of 1.45. Track Telix Pharmaceutical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Telix Pharmaceutical Ltd. there?
Today Telix Pharmaceutical Ltd. has the market capitalization of ‪2.18 B‬, it has decreased by −2.46% over the last week.
Yes, you can track Telix Pharmaceutical Ltd. financials in yearly and quarterly reports right on TradingView.
Telix Pharmaceutical Ltd. is going to release the next earnings report on Aug 20, 2026. Keep track of upcoming events with our Earnings Calendar.
TLPPF earnings for the last half-year are −0.01 USD per share, whereas the estimation was 0.13 USD, resulting in a −105.10% surprise. The estimated earnings for the next half-year are 0.03 USD per share. See more details about Telix Pharmaceutical Ltd. earnings.
Telix Pharmaceutical Ltd. revenue for the last half-year amounts to ‪390.36 M‬ USD, despite the estimated figure of ‪390.49 M‬ USD. In the next half-year revenue is expected to reach ‪418.49 M‬ USD.
TLPPF net income for the last half-year is ‪−2.38 M‬ USD, while the previous report showed ‪12.54 M‬ USD of net income which accounts for −118.95% change. Track more Telix Pharmaceutical Ltd. financial stats to get the full picture.
No, TLPPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Telix Pharmaceutical Ltd. EBITDA is ‪43.45 M‬ USD, and current EBITDA margin is 11.52%. See more stats in Telix Pharmaceutical Ltd. financial statements.
Like other stocks, TLPPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telix Pharmaceutical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Telix Pharmaceutical Ltd. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Telix Pharmaceutical Ltd. stock shows the sell signal. See more of Telix Pharmaceutical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.